Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-24-081626
Filing Date
2024-07-23
Accepted
2024-07-23 06:01:18
Documents
29

Document Format Files

Seq Description Document Type Size
1 S-1/A tm247121-36_s1a.htm S-1/A 3588417
2 EXHIBIT 5.1 tm247121d37_ex5-1.htm EX-5.1 7846
3 EXHIBIT 23.1 tm247121d37_ex23-1.htm EX-23.1 2390
4 EX-FILING FEES tm247121d37_ex-filingfees.htm EX-FILING FEES 20935
5 GRAPHIC tm247121d37_ex5-1img001.jpg GRAPHIC 13735
6 GRAPHIC lg_actuatetherape-4clr.jpg GRAPHIC 9987
7 GRAPHIC fc_multimoa-4c.jpg GRAPHIC 92226
8 GRAPHIC lc_elraglarit-4clr.jpg GRAPHIC 41185
9 GRAPHIC tb_route-4c.jpg GRAPHIC 21300
10 GRAPHIC fc_tcellnk-4c.jpg GRAPHIC 106432
11 GRAPHIC fc_clinistud-4c.jpg GRAPHIC 89173
12 GRAPHIC bc_1801part-4c.jpg GRAPHIC 89107
13 GRAPHIC bc_overallsurvi-4c.jpg GRAPHIC 82204
14 GRAPHIC tb_adverseevent-4c.jpg GRAPHIC 113661
15 GRAPHIC bc_1801part2-4c.jpg GRAPHIC 68096
16 GRAPHIC ph_mri12week-bw.jpg GRAPHIC 155512
17 GRAPHIC lc_elrainje-4c.jpg GRAPHIC 54636
18 GRAPHIC bc_8moverl-4c.jpg GRAPHIC 85624
19 GRAPHIC tb_demographics-4c.jpg GRAPHIC 142867
20 GRAPHIC tb_general-4c.jpg GRAPHIC 55206
21 GRAPHIC tb_anatomical-4c.jpg GRAPHIC 33613
22 GRAPHIC lc_gnp-4c.jpg GRAPHIC 78483
23 GRAPHIC bc_1801part3b-4c.jpg GRAPHIC 50984
24 GRAPHIC bc_1801part3b2-4c.jpg GRAPHIC 58473
25 GRAPHIC tb_elraglusib-4c.jpg GRAPHIC 112050
26 GRAPHIC bc_alive-4c.jpg GRAPHIC 72968
27 GRAPHIC bc_stable-4c.jpg GRAPHIC 67129
28 GRAPHIC bc_partial-4c.jpg GRAPHIC 66295
29 GRAPHIC tb_patients-4c.jpg GRAPHIC 114028
  Complete submission text file 0001104659-24-081626.txt   6180796
Mailing Address 1751 RIVER RUN SUITE 400 FORT WORTH TX 76107
Business Address 1751 RIVER RUN SUITE 400 FORT WORTH TX 76107 847-986-4190
ACTUATE THERAPEUTICS, INC. (Filer) CIK: 0001652935 (see all company filings)

EIN.: 473044785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-279734 | Film No.: 241132824
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)